HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Circulating oxidized LDL is a useless test: measure ApoB instead, per Tom Dayspring

Louis Nervegna · Sep 12, 2025 · ♥ 11 reactions · 2 comments · original Facebook post
LDL, ApoB & lipid panelRisk assessment & lab tests
↻ This is a repost. The main version (highest ranked) is Circulating oxidized LDL is a poor test; measure ApoB instead, says Dayspring · Feb 04, 2024.
AI summary & key facts

Louis shares a clip of Tom Dayspring arguing that oxidized LDL measured in the bloodstream adds nothing beyond ApoB. He clarifies that oxidation inside plaques still matters, but happens after LDL enters the artery wall and cannot be measured by a blood test.

(no text — see the shared post below)

Research cited

Tom Dayspring: Circulating oxidized LDL in the bloodstream is a “useless” biomarker for heart disease.

He says not to waste your money on this test, and to measure ApoB instead.


Note that he is talking about the the oxidized LDL in blood circulation— not the oxidized LDL in plaques. The oxidized LDL in plaques still matters a lot. The oxidized LDL in plaques mostly happens after the LDL enters the plaque and leaves circulation. You can not measure this with a blood test unfortunately.

He is talking about LDL oxidizing in circulation before it enters the plaque. The newest studies that properly adjust for ApoB show that circulating oxidized LDL is NOT related to CVD risk. It is the ApoB that is actually causal, whether those particles are oxidized or not in circulation. The ApoB particles get oxidized anyway after they enter the plaque, which can not be measured. Whether or not they are oxidized before they enter plaque seems to make little difference.

#oxidizedldlHD #dayspringHD

← newer: Japan-ACS: pitavastatin and atorvastatin both regressed coroolder: Circulating oxidized LDL does not predict CVD once ApoB is a →